Chemokine and chemokine receptors in autoimmunity

the case of primary biliary cholangitis

Jinjung Choi, Carlo Selmi, Patrick S Leung, Thomas P. Kenny, Tania Roskams, M. Eric Gershwin

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

ABSTRACT: Chemokines represent a major mediator of innate immunity and play a key role in the selective recruitment of cells during localized inflammatory responses. Beyond critical extracellular mediators of leukocyte trafficking, chemokines and their cognate receptors are expressed by a variety of resident and infiltrating cells (monocytes, lymphocytes, NK cells, mast cells, and NKT cells). Chemokines represent ideal candidates for mechanistic studies (particularly in murine models) to better understand the pathogenesis of chronic inflammation and possibly become biomarkers of disease. Nonetheless, therapeutic approaches targeting chemokines have led to unsatisfactory results in rheumatoid arthritis, while biologics against pro-inflammatory cytokines are being used worldwide with success. In this comprehensive review we will discuss the evidence supporting the involvement of chemokines and their specific receptors in mediating the effector cell response, utilizing the autoimmune/primary biliary cholangitis setting as a paradigm.

Original languageEnglish (US)
Pages (from-to)661-672
Number of pages12
JournalExpert Review of Clinical Immunology
Volume12
Issue number6
DOIs
StatePublished - Jun 2 2016

Fingerprint

Cholangitis
Chemokine Receptors
Autoimmunity
Chemokines
Natural Killer T-Cells
Biological Products
Innate Immunity
Mast Cells
Natural Killer Cells
Monocytes
Rheumatoid Arthritis
Leukocytes
Biomarkers
Lymphocytes
Cytokines
Inflammation

Keywords

  • autoimmune cholangitis
  • biologics
  • chemokine receptor
  • Innate immunity
  • monoclonal antibody
  • tolerance breakdown

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Chemokine and chemokine receptors in autoimmunity : the case of primary biliary cholangitis. / Choi, Jinjung; Selmi, Carlo; Leung, Patrick S; Kenny, Thomas P.; Roskams, Tania; Gershwin, M. Eric.

In: Expert Review of Clinical Immunology, Vol. 12, No. 6, 02.06.2016, p. 661-672.

Research output: Contribution to journalReview article

Choi, Jinjung ; Selmi, Carlo ; Leung, Patrick S ; Kenny, Thomas P. ; Roskams, Tania ; Gershwin, M. Eric. / Chemokine and chemokine receptors in autoimmunity : the case of primary biliary cholangitis. In: Expert Review of Clinical Immunology. 2016 ; Vol. 12, No. 6. pp. 661-672.
@article{392c0cfef8e4446e9771c19d1899ac9d,
title = "Chemokine and chemokine receptors in autoimmunity: the case of primary biliary cholangitis",
abstract = "ABSTRACT: Chemokines represent a major mediator of innate immunity and play a key role in the selective recruitment of cells during localized inflammatory responses. Beyond critical extracellular mediators of leukocyte trafficking, chemokines and their cognate receptors are expressed by a variety of resident and infiltrating cells (monocytes, lymphocytes, NK cells, mast cells, and NKT cells). Chemokines represent ideal candidates for mechanistic studies (particularly in murine models) to better understand the pathogenesis of chronic inflammation and possibly become biomarkers of disease. Nonetheless, therapeutic approaches targeting chemokines have led to unsatisfactory results in rheumatoid arthritis, while biologics against pro-inflammatory cytokines are being used worldwide with success. In this comprehensive review we will discuss the evidence supporting the involvement of chemokines and their specific receptors in mediating the effector cell response, utilizing the autoimmune/primary biliary cholangitis setting as a paradigm.",
keywords = "autoimmune cholangitis, biologics, chemokine receptor, Innate immunity, monoclonal antibody, tolerance breakdown",
author = "Jinjung Choi and Carlo Selmi and Leung, {Patrick S} and Kenny, {Thomas P.} and Tania Roskams and Gershwin, {M. Eric}",
year = "2016",
month = "6",
day = "2",
doi = "10.1586/1744666X.2016.1147956",
language = "English (US)",
volume = "12",
pages = "661--672",
journal = "Expert Review of Clinical Immunology",
issn = "1744-666X",
publisher = "Expert Reviews Ltd.",
number = "6",

}

TY - JOUR

T1 - Chemokine and chemokine receptors in autoimmunity

T2 - the case of primary biliary cholangitis

AU - Choi, Jinjung

AU - Selmi, Carlo

AU - Leung, Patrick S

AU - Kenny, Thomas P.

AU - Roskams, Tania

AU - Gershwin, M. Eric

PY - 2016/6/2

Y1 - 2016/6/2

N2 - ABSTRACT: Chemokines represent a major mediator of innate immunity and play a key role in the selective recruitment of cells during localized inflammatory responses. Beyond critical extracellular mediators of leukocyte trafficking, chemokines and their cognate receptors are expressed by a variety of resident and infiltrating cells (monocytes, lymphocytes, NK cells, mast cells, and NKT cells). Chemokines represent ideal candidates for mechanistic studies (particularly in murine models) to better understand the pathogenesis of chronic inflammation and possibly become biomarkers of disease. Nonetheless, therapeutic approaches targeting chemokines have led to unsatisfactory results in rheumatoid arthritis, while biologics against pro-inflammatory cytokines are being used worldwide with success. In this comprehensive review we will discuss the evidence supporting the involvement of chemokines and their specific receptors in mediating the effector cell response, utilizing the autoimmune/primary biliary cholangitis setting as a paradigm.

AB - ABSTRACT: Chemokines represent a major mediator of innate immunity and play a key role in the selective recruitment of cells during localized inflammatory responses. Beyond critical extracellular mediators of leukocyte trafficking, chemokines and their cognate receptors are expressed by a variety of resident and infiltrating cells (monocytes, lymphocytes, NK cells, mast cells, and NKT cells). Chemokines represent ideal candidates for mechanistic studies (particularly in murine models) to better understand the pathogenesis of chronic inflammation and possibly become biomarkers of disease. Nonetheless, therapeutic approaches targeting chemokines have led to unsatisfactory results in rheumatoid arthritis, while biologics against pro-inflammatory cytokines are being used worldwide with success. In this comprehensive review we will discuss the evidence supporting the involvement of chemokines and their specific receptors in mediating the effector cell response, utilizing the autoimmune/primary biliary cholangitis setting as a paradigm.

KW - autoimmune cholangitis

KW - biologics

KW - chemokine receptor

KW - Innate immunity

KW - monoclonal antibody

KW - tolerance breakdown

UR - http://www.scopus.com/inward/record.url?scp=84959064216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959064216&partnerID=8YFLogxK

U2 - 10.1586/1744666X.2016.1147956

DO - 10.1586/1744666X.2016.1147956

M3 - Review article

VL - 12

SP - 661

EP - 672

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

SN - 1744-666X

IS - 6

ER -